Universal Health Services Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Revises Earnings Guidance for the Year Ended December 31, 2015
Jul 30 15
Universal Health Services Inc. reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the second quarter, the company reported net revenues of $2,275,204,000 against $2,051,766,000 a year ago. Income from operations was $335,392,000 against $293,432,000 a year ago. Income before income taxes was $307,708,000 against $258,345,000 a year ago. Net income attributable to the company was $182,193,000 against $151,671,000 a year ago. Diluted earnings per share attributable to the company were $1.80 against $1.51 a year ago. EBITDA was $413,438,000 against $369,180,000 a year ago. Adjusted net income attributable to the company was $186,551,000 against $155,586,000 a year ago. Capital expenditures were $81,304,000 against $94,399,000 a year ago.
For the six months, the company reported net revenues of $4,500,557,000 against $3,990,080,000 a year ago. Income from operations was $662,446,000 against $564,408,000 a year ago. Income before income taxes was $604,725,000 against $494,128,000 a year ago. Net income attributable to the company was $356,492,000 against $289,749,000 a year ago. Diluted earnings per share attributable to the company were $3.54 against $2.89 a year ago. EBITDA was $819,466,000 against $719,741,000 a year ago. Adjusted net income attributable to the company was $366,083,000 against $292,280,000 a year ago. Net cash provided by operating activities was $531,603,000 against $458,416,000 a year ago. Acquisition of property and businesses was $34,500,000 against $71,000,000 a year ago. Capital expenditures were $170,580,000 against $186,786,000 a year ago.
Based upon the operating trends and financial results experienced during the first six months of 2015, the company increasing estimated range of adjusted net income attributable to UHS, for the year ended December 31, 2015, to $6.75 to $7.15 per diluted share. This revised guidance, which excludes the expected EHR impact for the year, represents an increase of approximately 9% to 10% from the previously provided range of $6.15 to $6.55 per diluted share.